National Surgical Adjuvant Breast and Bowel Project
5
Bernard Fisher,
Bernard Fisher
National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA
Search for more papers by this authorBernard Fisher,
Bernard Fisher
National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA
Search for more papers by this authorFirst published: 15 July 2005
References
- 1 Bonadonna, G., Brusamolino, E., Valagussa, P., Rossi, A., Brugnatelli, L., Brambilla, C., DeLena, M., Tancini, G., Bajetta, E., Musumeci, R. & Veronesi, U. (1976). Combination chemotherapy as an adjuvant treatment in operable breast cancer, New England Journal of Medicine 294, 405–410.
- 2 Bryant, J., Fisher, B., Gunduz, N., Costantino, J. P. & Emir, B. (1998). S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen-receptor-positive breast cancer, Breast Cancer Research and Treatment 51, 239–253.
- 3 Consensus Conference. (1985) Adjuvant Chemotherapy for Breast Cancer. Journal of the American Medical Association 254, 3461–3463.
- 4 Day, R., Ganz, P. A., Costantino, J. P., Cronin, W. M., Wickerham, D. L. & Fisher, B. (1999). Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 study, Journal of Clinical Oncology 17, 2659–2669.
- 5 Fisher, B. (1970). The surgical dilemma in the primary therapy of invasive breast cancer: a critical appraisal, Current Problems in Surgery October, 1–53.
- 6 Fisher, B. (1980). Laboratory and clinical research in breast cancer: a personal adventure: the David A. Karnofsky memorial lecture, Cancer Research 40, 3863–3874.
- 7 Fisher, B. (1996). A commentary on endometrial cancer deaths in tamoxifen-treated breast cancer patients, Journal of Clinical Oncology 14, 1027–1039.
- 8 Fisher, B. (1999). National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial: a reflective commentary, Journal of Clinical Oncology 17, 1632–1639.
- 9 Fisher, B. & Redmond, C. (1991). New perspective on cancer of the contralateral breast: a marker for assessing tamoxifen as a preventive agent, Journal of the National Cancer Institute 83, 1278–1280.
- 10 Fisher, B., Ravdin, R. G., Ausman, R. K., Slack, N. H., Moore, G. E. & Noer, R. J. (1968). Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation, Annals of Surgery 168, 337–356.
- 11 Fisher, B., Slack, N. H., Cavanaugh, P. J., Gardner, B. & Ravdin, R. G. (1970). Postoperative radiotherapy in the treatment of breast cancer: results of the NSABP clinical trial, Annals of Surgery 172, 711–732.
- 12 Fisher, B., Slack, N., Katrych, D. & Wolmark, N. (1975). Ten-year follow-up results of patients with carcinoma of the breast in a cooperative clinical trial evaluating surgical adjuvant chemotherapy, Surgery, Gynecology and Obstetrics 140, 528–534.
- 13 Fisher, B., Carbone, P., Economou, S. G., Frelick, R., Glass, A., Lerner, H., Redmond, C., Zelen, M., Band, P., Katrych, D. L., Wolmark, N. & Fisher, E. R. (1975). L-phenylalanine mustard (L-PAM) in the management of primary breast cancer: a report of early findings, New England Journal of Medicine 292, 117–122.
- 14
Fisher, B.,
Montague, E.,
Redmond, C.,
Barton, B.,
Borland, D.,
Fisher, E. R.,
Deutsch, M.,
Schwarz, G.,
Margolese, R.,
Donegan, W.,
Volk, H.,
Konvolinka, C.,
Gardner, B.,
Cohn, I.,
Lesnick, G.,
Cruz, A. B.,
Lawrence, W.,
Nealon, T.,
Butcher, H. &
Lawton, R.
(1977).
Comparison of radical mastectomy with alternative treatments for primary breast cancer: a first report of results from a prospective randomized clinical trial,
Cancer
39, Supplement 6,
2827–2839.
10.1002/1097-0142(197706)39:6<2827::AID-CNCR2820390671>3.0.CO;2-I PubMed Web of Science® Google Scholar
- 15 Fisher, B., Bauer, M., Margolese, R., Poisson, R., Pilch, Y., Redmond, C., Fisher, E., Wolmark, N., Deutsch, M., Montague, E., Saffer, E., Wickerham, L., Lerner, H., Glass, A., Shibata, H., Deckers, P., Ketcham, A., Oishi, R. & Russell, I. (1985). Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer, New England Journal of Medicine 312, 665–673.
- 16 Fisher, B., Redmond, C., Dimitrov, N. V., Bowman, D., Legault-Poisson, S., Wickerham, D. L., Wolmark, N., Fisher, E. R., Margolese, R., Sutherland, C., Glass, A., Foster, R. & Caplan, R. (1989). A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors, New England Journal of Medicine 320, 473–478.
- 17 Fisher, B., Costantino, J., Redmond, C., Poisson, R., Bowman, D., Couture, J., Dimitrov, N. V., Wolmark, N., Wickerham, D. L., Fisher, E. R., Margolese, R., Robidoux, A., Shibata, H., Terz, J., Paterson, A. H. G., Feldman, M. I., Farrar, W., Evans, J., Lickley, H. L. & Ketner, M. (1989). A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors, New England Journal of Medicine 320, 479–484.
- 18 Fisher, B., Brown, A. M., Dimitrov, N. V., Poisson, R., Redmond, C., Margolese, R. G., Bowman, D., Wolmark, N., Wickerham, D. L., Kardinal, C. G., Shibata, H., Paterson, A. H. G., Sutherland, C. M., Robert, N. J., Ager, P. J., Levy, L., Wolter, J., Wozniak, T., Fisher, E. R. & Deutsch, M. (1990). Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with six months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from NSABP B-15, Journal of Clinical Oncology 8, 1483–1496.
- 19 Fisher, B., Redmond, C., Legault-Poisson, S., Dimitrov, N. V., Brown, A. M., Wickerham, D. L., Wolmark, N., Margolese, R. G., Bowman, D., Glass, A. G., Kardinal, C. G., Robidoux, A., Jochimsen, P., Cronin, W., Deutsch, M., Fisher, E. R., Myers, D. B. & Hoehn, J. L. (1990). Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16, Journal of Clinical Oncology 8, 1005–1018.
- 20 Fisher, B., Costantino, J., Redmond, C., Fisher, E. R., Margolese, R., Dimitrov, N., Wickerham, D. L., Wolmark, N., Deutsch, M., Ore, L., Mamounas, E. & Kavanah, M. (1993). Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer, New England Journal of Medicine 328, 1581–1586.
- 21 Fisher, B., Costantino, J. P., Redmond, C., Fisher, E. R., Wickerham, D. L. & Cronin, W. (1994). Endometrial cancer in tamoxifen-treated breast cancer patients: findings from NSABP B-14, Journal of the National Cancer Institute 86, 527–537.
- 22 Fisher, B., Anderson, S., Redmond, C., Wolmark, N., Wickerham, L. & Cronin, W. (1995). Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer, New England Journal of Medicine 333, 1456–1461.
- 23 Fisher, B., Dignam, J., Mamounas, E. P., Costantino, J. P., Wickerham, D. L., Redmond, C., Wolmark, N., Dimitrov, N. V., Bowman, D. M., Glass, A. G., Atkins, J. N., Abramson, N., Sutherland, C. M., Aron, B. S. & Margolese, R. G. (1996). Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil, Journal of Clinical Oncology 14, 1982–1992.
- 24 Fisher, B., Dignam, J., Bryant, J., DeCillis, A., Wickerham, D. L., Wolmark, N., Costantino, J., Redmond, C., Fisher, E. R., Bowman, D. M., Deschenes, L., Dimitrov, N. V., Margolese, R. G., Robidoux, A., Shibata, H., Terz, J., Paterson, A. H. G., Feldman, M. I., Farrar, W., Evans, J. & Lickley, H. L. (1996). Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors, Journal of the National Cancer Institute 88, 1529–1542.
- 25 Fisher, B., Anderson, S., Wickerham, D. L., DeCillis, A., Dimitrov, N., Mamounas, E., Wolmark, N., Pugh, R., Atkins, J. N., Meyers, F. J., Abramson, N., Wolter, J., Bornstein, R. S., Levy, L., Romond, E. H., Caggiano, V., Grimaldi, M., Jochimsen, P. & Deckers, P. (1997). Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22, Journal of Clinical Oncology 15, 1858–1869.
- 26 Fisher, B., Dignam, J., Wolmark, N., DeCillis, A., Emir, B., Wickerham, D. L., Bryant, J., Dimitrov, N. V., Abramson, N., Atkins, J. N., Shibata, H., Deschenes, L. & Margolese, R. G. (1997). Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer, Journal of the National Cancer Institute 89, 1673–1682.
- 27 Fisher, B., Brown, A., Mamounas, E., Wieand, S., Robidoux, A., Margolese, G., Cruz, A. B., Fisher, E. R., Wickerham, D. L., Wolmark, N., DeCillis, A., Hoehn, J. L., Lees, A. W. & Dimitrov, N. V. (1997). Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18, Journal of Clinical Oncology 15, 2483–2493.
- 28 Fisher, B., Bryant, J., Wolmark, N., Mamounas, E., Brown, A., Fisher, E. R., Wickerham, D. L., Begovic, M., DeCillis, A., Robidoux, A., Margolese, R. G., Cruz, A. B. Jr, Hoehn, J. L., Lees, A. W., Dimitrov, N. V. & Bear, H. D. (1998). Effect of preoperative chemotherapy on the outcome of women with operable breast cancer, Journal of Clinical Oncology 16, 2672–2685.
- 29 Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N. V., Atkins, J., Daly, M., Wieand, S., Tan-Chiu, E., Ford, L., Wolmark, N. & other National Surgical Adjuvant Breast and Bowel Project Investigators (1998). Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study, Journal of the National Cancer Institute 90, 1371–1388.
- 30 Fisher, B., Dignam, J., Wolmark, N., Wickerham, D. L., Fisher, E. R., Mamounas, E., Smith, R., Begovic, M., Dimitrov, N. V., Margolese, R. G., Kardinal, C. G., Kavanah, M. T., Fehrenbacher, L. & Oishi, R. H. (1999). Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial, Lancet 353, 1993–2000.
- 31 Ganz, P. A., Day, R., Ware, J. E. Jr, Redmond, C. & Fisher, B. (1995). Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project breast cancer prevention trial, Journal of the National Cancer Institute 87, 1372–1382.
- 32 Gorin, M. B., Day, R., Costantino, J. P., Fisher, B., Redmond, C. K., Wickerham, L., Gomolin, J. E., Margolese, R. G., Mathen, M. K., Bowman, D. M., Kaufman, D. I., Dimitrov, N. V., Singerman, L. J., Bornstein, R., Wolmark, N. & Kaufman, D. (1998). Long-term tamoxifen citrate use and potential ocular toxicity, American Journal of Ophthalmology 125, 493–501.
- 33 Progress Report of the National Surgical Adjuvant Breast and Bowel Project (1998). 17–24.
- 34 Ravdin, R. G., Lewison, E. F., Slack, N. H., Dao, T. L., Gardner, B., State, D. & Fisher, B. (1970). Results of a clinical trial concerning the worth of prophylactic oophorectomy for breast carcinoma, Surgery, Gynecology and Obstetrics 131, 1055–1064.
- 35
Skipper, H. E.
(1971).
Kinetics of mammary tumor cell growth and implications for therapy,
Cancer
28,
1479–1499.
10.1002/1097-0142(197112)28:6<1479::AID-CNCR2820280622>3.0.CO;2-M CAS PubMed Web of Science® Google Scholar
- 36 Skipper, H. E. & Schabel, F. M., Jr (1973). Quantitative and cytokinetic studies in experimental tumor models, in Cancer Medicine, J. F. Holland & E. Frei III, eds. Lea & Febiger, Philadelphia, pp. 629–650.
